IMPROVING UTILIZATION OF SGLT-2 INHIBITORS IN VETERANS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE IN A VA PRIMARY CARE CLINIC

被引：0
|
作者：
Anderson, Rachel [1 ]
Day, Jonathan [1 ]
de la Serna, Solanus [1 ]
Hines, Mackenzie [1 ]
Prathivadhi-Bhayankaram, Sruti [1 ]
Salomone, Joseph [1 ]
Vather, Naomi [1 ]
Zandvakili, Arya [1 ]
Brettell, Leslie [1 ]
Johnson, Krista M. [2 ]
Hupp, Derek [3 ]
机构：
[1] Univ Iowa Hosp & Clin, Internal Med, Iowa City, IA USA
[2] Univ Iowa, Internal Med, Iowa City, IA USA
[3] Iowa City VA Med Ctr, Internal Med, Iowa City, IA USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S695 / S695
页数：1
相关论文
共 50 条
  • [41] The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
    Sanchez-Briales, Paula
    Vidas, Maria Marques
    Lopez-Sanchez, Paula
    Lopez-Illazquez, Maria Victoria
    Martin-Testillano, Lucia
    Vedat-Ali, Aylin
    Portoles, Jose
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [42] A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
    Lucia Del Vecchio
    Angelo Beretta
    Carlo Jovane
    Silvia Peiti
    Simonetta Genovesi
    Drugs, 2021, 81 : 1491 - 1511
  • [43] Value of SGLT-2 inhibitors in the treatment of chronic kidney disease Clinical and practical implications
    Saemann, Marcus
    Cejka, Daniel
    Schmaldienst, Sabine
    Rosenkranz, Alexander R.
    Mayer, Gert
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (3-4) : 97 - 109
  • [44] Early Introduction of SGLT-2 Inhibitors to Improve Chronic Kidney Disease Care in People with or without Diabetes-Consensus by Indian Nephrologists
    Sahay, Manisha
    Prakash, Sunil
    Kataruka, Manik
    Shah, Hardik
    Anthuvan, Thamburaj
    Gadia, Smriti
    Prasad, Ashish
    Gupta, Amit
    JOURNAL OF DIABETOLOGY, 2025, 16 (02) : 123 - 137
  • [45] A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
    Del Vecchio, Lucia
    Beretta, Angelo
    Jovane, Carlo
    Peiti, Silvia
    Genovesi, Simonetta
    DRUGS, 2021, 81 (13) : 1491 - 1511
  • [46] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Dekkers, Claire C. J.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT DIABETES REPORTS, 2018, 18 (05)
  • [47] The effects of the SGLT2 inhibitors on the Japanese type 2 diabetes patients with chronic kidney disease
    Kobayashi, K.
    Sato, K.
    Hatori, N.
    Miyakawa, M.
    Toyoda, M.
    DIABETOLOGIA, 2017, 60 : S418 - S418
  • [48] PRIMARY CARE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASE - ARE WE MISSING A TRICK?
    Higson, David
    Turley, Andrew
    HEART, 2021, 107 : A153 - A154
  • [49] Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02) : S13 - S16
  • [50] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
12345